These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37713175)

  • 1. Pegylated-l-asparaginase therapy for feline large cell lymphoma: 82 cases (2017-2020).
    Bik CA; Ruijter BR; Van den Bossche L; Teske E; Niessen SJ; Forcada Y
    J Feline Med Surg; 2023 Sep; 25(9):1098612X231193536. PubMed ID: 37713175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylated asparaginase in feline high-grade lymphoma: clinical results of single injection and continued incorporation into a modified COP regimen.
    Krupa A; de Vos J; Van Eetvelde L; Teske E
    J Feline Med Surg; 2022 Aug; 24(8):e203-e213. PubMed ID: 35748790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy for Australian cats with lymphosarcoma.
    Malik R; Gabor LJ; Foster SF; McCorkell BE; Canfield PJ
    Aust Vet J; 2001 Dec; 79(12):808-17. PubMed ID: 11837901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a multiagent chemotherapy protocol combining vincristine, cyclophosphamide, mitoxantrone and prednisolone (CMOP) for treatment of feline intermediate-large cell lymphoma.
    Webster J; McNaught KA; Morris JS
    J Feline Med Surg; 2024 Apr; 26(4):1098612X241234614. PubMed ID: 38647264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal Type.
    Kim HJ; Ock CY; Kim TM; Lee SH; Lee JY; Jung SH; Cho YS; Kim M; Keam B; Kim DW; Kim IH; Heo DS
    Cancer Res Treat; 2018 Jul; 50(3):670-680. PubMed ID: 28675023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and adverse events of L-Asparaginase administration as a first-line treatment for feline large-cell gastrointestinal lymphoma.
    Inazumi H; Toyoda H; Shimano S; Sakuma H; Sakamoto M; Nakagawa T; Fukuoka R; Ohmi A; Chambers JK; Uchida K; Goto-Koshino Y; Tomiyasu H
    J Vet Med Sci; 2024 Jul; 86(7):727-736. PubMed ID: 38825481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of feline intermediate to high-grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017-2021).
    Moore AS; Frimberger AE
    Vet Comp Oncol; 2024 Mar; 22(1):106-114. PubMed ID: 38152842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and adverse events of continuous l-asparaginase administration for canine large cell lymphoma of presumed gastrointestinal origin.
    Nakagawa T; Kojima M; Ohno K; Chambers JK; Uchida K; Ohmi A; Goto-Koshino Y; Tomiyasu H; Tsujimoto H
    Vet Comp Oncol; 2022 Mar; 20(1):102-108. PubMed ID: 34213084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993-1997).
    Zwahlen CH; Lucroy MD; Kraegel SA; Madewell BR
    J Am Vet Med Assoc; 1998 Oct; 213(8):1144-9. PubMed ID: 9787382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and treatment of feline renal lymphoma: 27 cases.
    Williams AG; Hohenhaus AE; Lamb KE
    J Feline Med Surg; 2021 Oct; 23(10):936-944. PubMed ID: 33464143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of L-asparaginase: polyethylene glycol conjugate versus native L-asparaginase combined with chemotherapy. A randomized double-blind study in canine lymphoma.
    MacEwen EG; Rosenthal RC; Fox LE; Loar AS; Kurzman ID
    J Vet Intern Med; 1992; 6(4):230-4. PubMed ID: 1522554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia.
    Ettinger LJ; Kurtzberg J; Voûte PA; Jürgens H; Halpern SL
    Cancer; 1995 Mar; 75(5):1176-81. PubMed ID: 7850718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).
    Dinndorf PA; Gootenberg J; Cohen MH; Keegan P; Pazdur R
    Oncologist; 2007 Aug; 12(8):991-8. PubMed ID: 17766659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
    Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
    Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged first-line PEG-asparaginase treatment in pediatric acute lymphoblastic leukemia in the NOPHO ALL2008 protocol-Pharmacokinetics and antibody formation.
    Tram Henriksen L; Gottschalk Højfeldt S; Schmiegelow K; Frandsen TL; Skov Wehner P; Schrøder H; Klug Albertsen B;
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28660740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of L-asparaginase on plasma amino acid profiles and tumor burden in cats with lymphoma.
    LeBlanc AK; Cox SK; Kirk CA; Newman SJ; Bartges JW; Legendre AM
    J Vet Intern Med; 2007; 21(4):760-3. PubMed ID: 17708396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feline extranodal lymphoma: response to chemotherapy and survival in 110 cats.
    Taylor SS; Goodfellow MR; Browne WJ; Walding B; Murphy S; Tzannes S; Gerou-Ferriani M; Schwartz A; Dobson JM
    J Small Anim Pract; 2009 Nov; 50(11):584-92. PubMed ID: 19891724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A five
    Vittayawacharin P; Khuhapinant A
    Hematology; 2021 Dec; 26(1):75-82. PubMed ID: 33427594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Safety and adverse event profiling of pegylated L-asparaginase combined chemotherapy in the treatment of lymphoma].
    Ping LY; Zheng W; Wang XP; Xie Y; Lin NJ; Tu MF; Ying ZT; Zhang C; Liu WP; Deng LJ; Zhu J; Song YQ
    Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(46):3257-60. PubMed ID: 23328509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.
    Toksvang LN; De Pietri S; Nielsen SN; Nersting J; Albertsen BK; Wehner PS; Rosthøj S; Lähteenmäki PM; Nilsson D; Nystad TA; Grell K; Frandsen TL; Schmiegelow K
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28423235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.